Welcome to Myeloma News.com!
WELCOME TO MYELOMA NEWS.COM!
My name is Pat Killingsworth, and I have multiple myeloma. I am disabled now, but I still work part-time as a freelance medical writer, covering cancer related conferences and interviewing the brightest myeloma experts from around the world. I try and report on the information I gather from a patient's perspective.
HERE IS HOW IT WORKS: Each story features a short description. Below that you will find a headline. If you would like to read more, simply click-on the headline, and it will take you directly to the source. Quick and easy!
I share my opinions about these and other topics on my daily blog: www.MultipleMyelomaBlog.com.
Good luck and remember: Feel good and keep smiling! Pat
My name is Pat Killingsworth, and I have multiple myeloma. I am disabled now, but I still work part-time as a freelance medical writer, covering cancer related conferences and interviewing the brightest myeloma experts from around the world. I try and report on the information I gather from a patient's perspective.
HERE IS HOW IT WORKS: Each story features a short description. Below that you will find a headline. If you would like to read more, simply click-on the headline, and it will take you directly to the source. Quick and easy!
I share my opinions about these and other topics on my daily blog: www.MultipleMyelomaBlog.com.
Good luck and remember: Feel good and keep smiling! Pat
Monday, June 13, 2011
BREAKING NEWS: Is there going to be a type of "oral Velcade" in our future? Millennium reports results from two MLN9708 ongoing Phase I studies on multiple myeloma
Phase I studies with MLN9708, the first oral proteasome inhibitor being studied in patients with relapsed and/or refractory multiple myeloma
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment